Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
To understand treatment practices for bipolar disorders, this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well-characterized individuals with BD.
BD² accelerates research-to-care translation so people with bipolar disorder can thrive. With over $60 million in funding, Dr. Cara Altimus, Dr. Emily Baxi, & Dr. Daniel Pham highlight how collaboration drives progress.
This report provides an overview of FTD research and funding patterns. It also identifies opportunities for philanthropists to invest in groundbreaking research to improve outcomes and quality of life for FTD patients.
This panel explores how philanthropy can help rebuild the health ecosystem in the wake of systemic inequities and recent policy shifts, and make it more equitable. Speakers emphasize the importance of diverse perspectives in driving innovation and improving outcomes across science and health.
Packard Center founder Dr. Jeffrey Rothstein joined experts at the Milken Institute Future of Health Summit to discuss advancing open science, transparency, and collaboration in research.
Featuring Jeffrey Rothstein, this panel explores how patients and nonprofits can help advance transparency and collaboration in biomedical research.
Follicular lymphoma is a slow-growing, incurable cancer. SPARC and the Follicular Lymphoma Foundation identified emerging therapies and key opportunities to accelerate progress toward a cure.
This first peer-reviewed collection on misophonia explores the condition’s defining features, triggers, and emerging research into its causes.
Pediatric brain cancer is the leading cause of cancer death in children. SPARC’s Giving Smarter Guide outlines key opportunities for philanthropy to strengthen research infrastructure and transform care for young patients.
Brain cancer is the leading cause of cancer death in children and teens. A transformative philanthropic gift is now reshaping the field by supporting new therapies, patient care, and collaborative research.
The Milken Institute Center for Strategic Philanthropy celebrates a $96 million gift to Children’s National Hospital supporting research, innovation, and family care for children with brain cancer.
Children’s National Hospital has received a $96 million donation from an anonymous donor family. The hospital will use it to advance brain tumor research in children.